The suppressive function of GAS2DN was also applicable to the primary CD34+ CML progenitor cells; which was the first time to demonstrate that GAS2DN inhibited the growth of progenitor cells from CML patients. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.